Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Sell
4,166
-2,055
-33% -$305K 0.01% 476
2026
Q1
$579K Buy
+6,221
New +$551K 0.01% 509
2024
Q2
Sell
-34
Closed -$3.82K 1164
2024
Q1
$3.82K Buy
+34
New +$4.05K ﹤0.01% 1013
2023
Q4
Sell
-79
Closed -$10.1K 1259
2023
Q3
$10.1K Sell
79
-6
-7% -$1.05K ﹤0.01% 892
2023
Q2
$15.6K Hold
85
﹤0.01% 889
2023
Q1
$11.3K Buy
+85
New +$9.99K ﹤0.01% 987

Other funds holding ACLS

BOK Financial's ACLS Position: Q2 2026 in Review

BOK Financial reduced its Axcelis (ACLS) stake by 33% in Q2 2026, selling an estimated $305K and leaving 4,166 shares worth $789K. The position accounts for 0.01% of the portfolio, ranked #476.

BOK Financial first reported a position in ACLS in Q1 2023 and has held it in 6 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • BOK Financial held 4,166 shares of Axcelis worth $789K as of Q2 2026.
  • BOK Financial sold 2,055 Axcelis shares in Q2 2026, an estimated $305K.
  • Axcelis made up 0.01% of BOK Financial's portfolio in Q2 2026, its #476 holding.
  • BOK Financial first reported a position in Axcelis in Q1 2023 and has held it in 6 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.